PerkinElmer, Inc. announced today that it expects revenues for the first quarter which ended March 31, 2002 to be in the range of $300-$305 million. Based on preliminary results PerkinElmer representatives said these results were approximately 10 percent lower than anticipated, which the company attributed to weakness in its Optoelectronics end markets, the deferral of capital spending by Analytical Instruments and Life Sciences customers. Also cited was sales force integration activities related to the merger with Packard BioSciences.
“The business environment has become very difficult. Customers in every sector are cautious about spending,” said Gregory L. Summe, chairman and chief executive officer of PerkinElmer. “Despite the difficult environment, we continue to build the strength of our customer franchises. We believe that the capability of our organization, processes and technology leadership will allow us to successfully weather the current market turbulence.”
The company, based in Wellesley, Mass., is scheduled to release final results for the first quarter and hold a conference call to discuss those results on Thursday, April 25, 2002, at 10:00 a.m.
No posts to display
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.












